Companies: 48,874 Total Market Cap: 132460447025120.92

Prenetics Global Limited

NASDAQ: PRE
Healthcare Diagnostics & Research
Rank #24697
Market Cap 90.33 M
Volume 81,356
Price 6.93
Change (%) 10.00%
Country or region Hong Kong Hong Kong

Prenetics Global Limited's latest marketcap:

90.33 M

As of 05/19/2025, Prenetics Global Limited's market capitalization has reached $90.33 M. According to our data, Prenetics Global Limited is the 24697th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 90.33 M
Revenue (ttm) 30.62 M
Net Income (ttm) -46,304,000
Shares Out 13.03 M
EPS (ttm) -3.71
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 06/17/2025
Market Cap Chart
Data Updated: 05/19/2025

Prenetics Global Limited's yearly market capitalization.

Prenetics Global Limited has seen its market value drop from $1.68 B to $90.33 M since 2021, representing a total decrease of 94.61% and an annual compound decline rate (CAGR) of 57.81%.
Date Market Cap Change (%)
05/19/2025 $90.33 M -0.9%
12/31/2024 $70.86 M -0.24%
12/29/2023 $71.03 M -68%
12/30/2022 $221.96 M -86.75%
12/31/2021 $1.68 B

Company Profile

About Prenetics Global Limited

Prenetics Global Limited is a forward-thinking health sciences company dedicated to advancing both consumer and clinical health through innovative solutions.

Consumer Health Initiatives

  • IM8: A leading health and wellness brand driving consumer-focused health initiatives.
  • CircleDNA: Utilizes next-generation sequencing (NGS) technology to provide comprehensive consumer DNA testing for preventive health insights.

Clinical Health & Genomic Solutions

The company specializes in multi-cancer early detection technologies and offers a suite of genomic profiling panels, including:

  • ACTOnco
  • ACT HRD
  • ACTFusion
  • ACTDrug

Advanced Diagnostic & Monitoring Solutions

  • ACTLiquid Pro: A sequencing-based liquid biopsy assay for pan-solid tumors.
  • ACTMonitor: Provides real-time monitoring of drug resistance, treatment response, and cancer recurrence.
  • ACT Risk: A specialized solution for managing cancer risk.

Additional Ventures

Prenetics is also engaged in sports distribution, supplying high-quality sports nutrition products to fitness facilities.

Global Presence

Founded in 2014 and headquartered in Quarry Bay, Hong Kong, the company operates across Taiwan, Hong Kong, the United Kingdom, and internationally, with a presence in the United States.

Frequently Asked Questions

As of 05/19/2025, Prenetics Global Limited (including the parent company, if applicable) has an estimated market capitalization of $90.33 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Prenetics Global Limited global market capitalization ranking is approximately 24697 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Hong Kong
Founded 2014
IPO Date n/a
Employees 285
CEO Sheng Wu Yeung
Sector Healthcare
Industry Diagnostics & Research
Address Unit 703-706, K11 Atelier King’s Road, 728 King’s Road
Quarry Bay
Hong Kong
Website https://www.prenetics.com
People Also Watch
TMO
413.92 10.00%
Danaher
196.41 10.00%
Lonza Group AG
687.27 10.00%
IDXX
521.68 10.00%